Downloads

31. Liposomal And Nanoparticle Technology 9/3/2025

    Specializing in oncology, anti-infective, and complex formulations, Pfizer Melbourne provides manufacturing services for sterile dosage forms.

32. When Single-Use Technology Becomes An Economic Imperative 9/3/2025

    Industry changes increasingly favor SUT for novel products, even while stainless steel remains an essential part of many process trains.

33. Unravelling The Complexities Of ADC Development And Manufacturing 9/3/2025

    Whether you're in the early stages of development or scaling up for commercialization, understanding ADC manufacturing challenges is essential for bringing life-saving therapies to patients worldwide.

34. The Case For Modernizing Small-Volume Aseptic Processing 9/2/2025

    Tube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative.

35. Cell Cycle Mapping In Tumors With Advanced Technologies 9/2/2025

    Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.

36. Building Quality By Design For Multi-Specific Therapeutic Proteins 9/2/2025

    Platforms incorporating high throughput in silico screening, in vitro expression, and immunosafety of multi-specific molecules can help mitigate potential developability risks and accelerate timelines.

37. GLP-1 Receptor Agonist Solutions 9/2/2025

    The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.

38. Analytical Tools To Address The Development Of GLP-1 Receptor Agonists 9/2/2025

    GLP-1 receptor agonists are revolutionizing therapeutics beyond diabetes. Explore analytical innovations that ensure safety and efficacy as these peptides expand into multiple treatments.

39. Lilly's Exploring A Universal AAV Purification Method 9/2/2025

    Serotype-specific resins don't scale gracefully. One team at Eli Lilly and Company is exploring an alternative that skips affinity resins altogether.

     

40. CSL Behring's Robotics Push Is One Of The Biggest We've Seen Yet 9/2/2025

    An expansion project, including an abundance of automation features, at the CSL's Victoria, Australia, campus earned the company an ISPE Facility of the Year Award.